SE442121B - Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider - Google Patents

Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider

Info

Publication number
SE442121B
SE442121B SE7708037A SE7708037A SE442121B SE 442121 B SE442121 B SE 442121B SE 7708037 A SE7708037 A SE 7708037A SE 7708037 A SE7708037 A SE 7708037A SE 442121 B SE442121 B SE 442121B
Authority
SE
Sweden
Prior art keywords
preparation
active peptides
analogy procedure
psychopharmacologically
psychopharmacologically active
Prior art date
Application number
SE7708037A
Other languages
English (en)
Other versions
SE7708037L (sv
Inventor
H M Greven
Wied D De
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of SE7708037L publication Critical patent/SE7708037L/sv
Publication of SE442121B publication Critical patent/SE442121B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7708037A 1976-07-12 1977-07-11 Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider SE442121B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7607683A NL7607683A (nl) 1976-07-12 1976-07-12 Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.

Publications (2)

Publication Number Publication Date
SE7708037L SE7708037L (sv) 1978-01-13
SE442121B true SE442121B (sv) 1985-12-02

Family

ID=19826578

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708037A SE442121B (sv) 1976-07-12 1977-07-11 Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider

Country Status (18)

Country Link
US (1) US4110322A (sv)
JP (1) JPS5325562A (sv)
AU (1) AU511395B2 (sv)
BE (1) BE856695A (sv)
CA (1) CA1109060A (sv)
CH (1) CH633523A5 (sv)
DE (1) DE2731282A1 (sv)
DK (1) DK149113B (sv)
ES (1) ES460618A1 (sv)
FI (1) FI67365C (sv)
FR (1) FR2358383A1 (sv)
GB (1) GB1566836A (sv)
HU (1) HU179665B (sv)
IE (1) IE45738B1 (sv)
LU (1) LU77739A1 (sv)
NL (1) NL7607683A (sv)
SE (1) SE442121B (sv)
ZA (1) ZA773935B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009010B1 (en) * 1978-07-18 1983-03-02 Kabi AB Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
GB2217319A (en) * 1988-04-19 1989-10-25 Synpharm Ltd Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi
ZA914684B (en) * 1990-07-18 1992-04-29 Akzo Nv Use of a centrally acting acth analog in the manufacture of a medicament
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
PE20130200A1 (es) * 2003-04-08 2013-03-09 Novartis Ag Composicion farmaceutica que contiene un agonista del receptor s1p y un alcohol de azucar
CA3110297A1 (en) * 2018-08-23 2020-02-27 Zion Medical B.V Pharmaceutical compositions comprising integration-promoting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.

Also Published As

Publication number Publication date
IE45738L (en) 1978-01-12
FI67365C (fi) 1985-03-11
AU2675277A (en) 1979-01-11
ES460618A1 (es) 1979-06-01
DK149113B (da) 1986-01-27
AU511395B2 (en) 1980-08-14
US4110322A (en) 1978-08-29
CH633523A5 (de) 1982-12-15
GB1566836A (en) 1980-05-08
ZA773935B (en) 1978-05-30
FR2358383A1 (fr) 1978-02-10
FI772155A (sv) 1978-01-13
JPS5325562A (en) 1978-03-09
DE2731282A1 (de) 1978-01-19
LU77739A1 (sv) 1977-10-14
SE7708037L (sv) 1978-01-13
FI67365B (fi) 1984-11-30
DK314277A (da) 1978-01-13
IE45738B1 (en) 1982-11-17
HU179665B (en) 1982-11-29
NL7607683A (nl) 1978-01-16
FR2358383B1 (sv) 1980-04-04
BE856695A (fr) 1978-01-11
CA1109060A (en) 1981-09-15

Similar Documents

Publication Publication Date Title
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO145915C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive karboksyalkylacylaminosyrer
NO147950C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO147913C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE442121B (sv) Analogiforfarande for framstellning av psykofarmakologiskt aktiva peptider
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO150888C (no) Fremgangsmaate for fremstilling av et encelle-protein
SE442205B (sv) Forfarande for framstellning av psykofarmakologiskt aktiva peptider och peptidderivat
NO770643L (no) Fremgangsmaate til fremstilling av bilologisk aktive kopolymerer
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
SE7707621L (sv) Forfarande for framstellning av xyloslosning
NO145540C (no) Fremgangsmaate for fremstilling av terapeutisk aktive polyribonukleotider
SE440500B (sv) Forfarande for framstellning av optiskt aktiva antracyklinoner
NO147028C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 1-hydroksyoktahydrobenzo(c)kinoliner
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler